CLONING AND FUNCTIONAL EXPRESSION OF THE HUMAN GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR

被引:163
|
作者
DILLON, JS
TANIZAWA, Y
WHEELER, MB
LENG, XH
LIGON, BB
RABIN, DU
YOOWARREN, H
PERMUTT, MA
BOYD, AE
机构
[1] MILES RES CTR, W HAVEN, CT USA
[2] WASHINGTON UNIV, SCH MED, DIV METAB, ST LOUIS, MO 63110 USA
关键词
D O I
10.1210/en.133.4.1907
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Truncated forms of glucagon-like peptide-1 are the most potent endogenous stimuli of insulin secretion and have powerful antidiabetogenic effects. To determine the structure and coupling mechanisms of the human GLP-1 receptor we have isolated two pancreatic islet cDNAs, encoding the 463 amino acid receptor and differing mainly in their 3' untranslated regions. The deduced amino acid sequence is 90% homologous with the rat GLP-1 receptor. Northern blot analysis shows expression of a single 2.7 kb transcript in pancreatic tissue. When expressed in COS-7 cells the recombinant receptor conferred specific, high affinity GLP-1(7-37) binding. GLP-1(7-37) increased intracellular cAMP in a concentration dependent manner and caused an increase in the free cytosolic calcium ([Ca2+]i) from an intracellular pool, characteristic of phospholipase C (PLC) activation. Thus, like the structurally related glucagon and parathyroid hormone receptors, the human GLP-1 receptor can activate multiple intracellular signaling pathways including adenylyl cyclase and PLC. Knowledge of the GLP-1 receptor structure will facilitate the development of receptor agonists and elucidation of the important role of GLP-1 in normal and disease states.
引用
收藏
页码:1907 / 1910
页数:4
相关论文
共 50 条
  • [31] An improved procedure for measurement of total glucagon-like peptide-1 (GLP-1) in human plasma
    Tanen, M
    Snyder, K
    Dallob, A
    Herman, G
    Wagner, J
    Gottesdiener, K
    Tanaka, W
    CLINICAL CHEMISTRY, 2004, 50 (06) : A107 - A107
  • [32] Progesterone Receptor Membrane Component 1 Is a Functional Part of the Glucagon-like Peptide-1 (GLP-1) Receptor Complex in Pancreatic β Cells
    Zhang, Ming
    Robitaille, Melanie
    Showalter, Aaron D.
    Huang, Xinyi
    Liu, Ying
    Bhattacharjee, Alpana
    Willard, Francis S.
    Han, Junfeng
    Froese, Sean
    Wei, Li
    Gaisano, Herbert Y.
    Angers, Stephane
    Sloop, Kyle W.
    Dai, Feihan F.
    Wheeler, Michael B.
    MOLECULAR & CELLULAR PROTEOMICS, 2014, 13 (11) : 3049 - 3062
  • [33] Glucagon-like peptide 1 (GLP-1) and eating
    Gutzwiller, JP
    Degen, L
    Heuss, L
    Beglinger, C
    PHYSIOLOGY & BEHAVIOR, 2004, 82 (01) : 17 - 19
  • [34] Glucagon-Like Peptide-1 (GLP-1) Receptor Expression on Human Umbilical Vein Endothelial Cells (HUVEC) in Response to Cellular Activation
    Noormohamed, Nadia
    Kiel, Dan
    FASEB JOURNAL, 2016, 30
  • [35] Reciprocal cellular distribution of glucagon-like peptide-1 (GLP-1) immunoreactivity and GLP-1 receptor mRNA in pancreatic islets of rat
    Horsch, D
    Goke, R
    Eissele, R
    Michel, B
    Goke, B
    PANCREAS, 1997, 14 (03) : 290 - 294
  • [36] Cellular and functional mechanisms underlying the gastroinhibitory effects of glucagon-like peptide-1 (GLP-1) in rat
    Holmes, Gregory M.
    Zheng, Zhongling
    Tong, Melissa
    Travagli, R. Alberto
    GASTROENTEROLOGY, 2008, 134 (04) : A390 - A390
  • [37] Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson's disease
    Glotfelty, Elliot J.
    Olson, Lars
    Karlsson, Tobias E.
    Li, Yazhou
    Greig, Nigel H.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (06) : 595 - 602
  • [38] Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology
    D. J. Drucker
    C. F. Rosen
    Diabetologia, 2011, 54 : 2741 - 2744
  • [39] Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment
    Kopp, Katherine O.
    Glotfelty, Elliot J.
    Li, Yazhou
    Greig, Nigel H.
    PHARMACOLOGICAL RESEARCH, 2022, 186
  • [40] Glucagon-like peptide-1 (GLP-1) receptor agonists for weight management: A review for the gynecologic oncologist
    Riedinger, Courtney J.
    Sakach, Julia
    Maples, Jill M.
    Fulton, Jessica
    Chippior, Jessica
    O'Donnell, Benjamin
    O'Malley, David M.
    Chambers, Laura M.
    GYNECOLOGIC ONCOLOGY, 2024, 190 : 1 - 10